MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Influence of age at onset on medication profile in patients with Parkinson’s disease: A prospective study from a tertiary care center in India

    VV. Holla, S. Prasad, T. Nagaraj, SGS. Bhat, M. Bhardwaj, DK. Samartha, SS. Nair, P. Mailankody, RR. Mahale, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: To study the effect of age at onset on the medication profile of various Parkinson's disease (PD) related medications. Background: Multiple factors determine the…
  • 2025 International Congress

    Medication Error Reduction Strategies in an In-patient Multimodal Intensive Neurorehabilitation and Care (i-MINC) Program

    N. Yousefzadeh, L. Hom, A. Defrank, M. Mccrossin, L. Rubin (Glen Cove, USA)

    Objective: To evaluate medication safety strategies implemented to reduce medication errors in an i-MINC Program Background: Medication mismanagement may lead to critical patient harm in…
  • 2025 International Congress

    Single- and Multi-Unit Activity in STN Provides Enhanced Insight into Speech-Related Neural Dynamics in Parkinson’s Patients

    Z. Jourahmad, A. Rohl, J. Greenlee (Iowa City, USA)

    Objective: We aimed to elucidate neural representations in local field potentials (LFP) and single- and multi-unit activity of subthalamic nucleus (STN) neurons during speech tasks,…
  • 2025 International Congress

    Platelets Lipidome as Potential Biomarker of Parkinson’s Disease

    G. Uras, S. Lucas-Del-Pozo, V. Lentini, F. Fierli, S. Koletsi, D. Hughes, A. Schapira, . (London, United Kingdom)

    Objective: The aim of this proejct is to identify novel biomarkers of Parkinson's disease diagnosis and progression, with a focus on GBA-PD. Background: Our previous…
  • 2025 International Congress

    Reduced plasma levels of small HDL subfractions in advanced Parkinson’s disease

    CM. Chen, KH. Chang, ML. Cheng (Taoyuan, Taiwan)

    Objective: The present study investigated alterations of circulatory lipoprotein profiles, including cholesterol, triglycerides (TGs), phospholipids (PLs) and apolipoproteins (Apo) in lipoprotein subfractions, in Parkinson's disease…
  • 2025 International Congress

    Long-term analysis of subthalamic local field potentials (LFP) in Parkinson’s disease: Insights into circadian rhythms, medication, and personalized treatment effects

    V. Livneh, R. Naivelt, M. Zutta, Z. Katzir, R. Monteoriano, I. Strauss, K. Avirame, A. Socher, G. Morris, I. Maidan (Tel Aviv, Israel)

    Objective: investigate electrophysiological patterns related to circadian rhythms, medication intake & long-term DBS effects. Background: Deep brain stimulation (DBS) offers substantial and long-lasting motor improvements…
  • 2025 International Congress

    Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

    C. Yu, C. Cooper (Nashville, USA)

    Objective: The goal of this study is to review the real-world application of alpha-synuclein skin biopsy at a tertiary care center. Background: Synucleniopathies including Parkinson’s…
  • 2025 International Congress

    The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)

    Objective: The scope of this work was to characterise the B-cell receptor repertoire of patients with Parkinson’s disease with dementia (PDD), cognitively resilient (PDR) and…
  • 2025 International Congress

    Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

    Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
  • 2025 International Congress

    Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

    T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: To evaluate the prevalence of visual misperception in patients with PD (PwP) in comparison with healthy control (HC) and its association with visual hallucinations.…
  • « Previous Page
  • 1
  • …
  • 152
  • 153
  • 154
  • 155
  • 156
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley